Eagle Pharmaceuticals Inc...

OTC: EGRX · Real-Time Price · USD
1.25
-0.25 (-16.67%)
At close: Apr 04, 2025, 3:30 PM

Eagle Pharmaceuticals Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Mar 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
n/a 10.61 -77.03
PEG Ratio
n/a -0.02 0.44
PS Ratio
n/a 1.19 3.87
PB Ratio
n/a 1.62 3.77
P/FCF Ratio
n/a 7.48 23.82
P/OCF Ratio
n/a 7.46 23.55
OCF/S Ratio
n/a 0.16 0.16
Debt / Equity Ratio
n/a 0.29 0.15
Quick Ratio
n/a 1.27 2.03
Current Ratio
n/a 1.70 2.32
Asset Turnover
n/a 0.78 0.68
Interest Coverage
n/a 20.01 -1.78
Return on Equity
n/a n/a n/a
Return on Assets
n/a n/a n/a
Return on Invested Capital
n/a n/a n/a
Dividend Yield
n/a n/a n/a
Payout Ratio
n/a n/a n/a
Gross Profit Margin
n/a 0.70 0.75
Net Profit Margin
n/a 0.11 -0.05
Pretax Profit Margin
n/a 0.19 -0.03
Operating Profit Margin
n/a 0.26 -0.02
FCF Margin
n/a n/a n/a
EBITDA Margin
n/a 0.24 0.02